Loading the company…
Loading the company…
㈜메디테크인프라메드
English name as filed with DART, Korea’s corporate disclosure system · Correct the English name ›
Last updated 2026-11-02 · Korean page ›
Verification level — how far we have checked
L0 · Public records — NPS workforce · filed financials · patents — public data
A company based in Seoul, founded in 2003. Industry: Wholesale & Retail. Revenue for 2025 was ₩25.4bn. It has 22 employees enrolled in the National Pension Service (as of Aug 2026). It is externally audited; the latest audit opinion is “Unqualified”.
Loading…
Latest filing 2018-11-15 · latest registration 2019-09-20 · newest first
본 발명은 해부학면 박리가 용이한 전기소작기에 관한 것으로서, 파지 가능한 소작기몸체와, 상기 소작기몸체의 전단에 구비되며, 전원공급을 받아 전기소작을 행하는 소작전극과, 상기 소작기몸체에 구비되며, 해부학면을 이루는 조직층 사이가 벌어지도록 소작전극의 전방으로 박리압을 가하는 박리압분사관을 포함한다. 이러한 본 발명에 따르면, 박리해야 할 해부학면을 쉽고 정확하게 찾을 수 있으며, 해부학면을 따라 보다 용이하고 신속하게 조직을 박리할 수 있는 효과가 있다.
KIPO KIPRIS · checked 2026-10-15 · newest filings first · right: registration date (filing date if not yet registered) · 1 of 1 · titles and abstracts are in Korean as filed · click a row for details ▾
For now we hold public records only (National Pension Service · DART filings · patents · registers · press). When the company files material in our IR Room, it moves to L1. We do not score or rate companies — we only state how far we have checked.
| KRW bn | 2024 | 2025 |
|---|---|---|
| Revenue | 21.8 | 25.4 |
| Cost of sales | 12.1 | 14.6 |
| Gross profit (loss) | 9.7 | 10.7 |
| Selling, general and administrative expenses | 7.2 | 8.2 |
| Operating income (loss) | 2.4 | 2.5 |
| Non-operating income | 0.8 | 1.1 |
| Other gains | 0.0 | 0.0 |
| Finance income | 0.1 | 0.1 |
| Other | 0.7 | 1.0 |
| Non-operating expenses | 0.1 | 0.1 |
| Other losses | 0.0 | 0.1 |
| Other | 0.1 | 0.0 |
| Profit (loss) before tax | 3.2 | 3.5 |
| Income tax expense | 1.1 | 0.7 |
| Net income (loss) | 2.0 | 2.8 |
Revenue ₩25.4bn, up 16.6% YoY.
Operating margin 9.9% (prior 11.2%).
Net income ₩2.8bn.
Need more than is shown here? Ask for more information — full review report · valuation · executive teaser · IM · competitor analysis · due diligence. Tell us what you need and we will reply by email with scope, cost and timing.
Is this your company?
If anything here is wrong, tell us — we check it against the original and correct it. You do not need to join. If you would like your financials verified and this page completed, that is a separate process.
Headlines and links to public articles only · not checked by us (original ↗) · articles are in Korean — English headlines are our translation; where none is shown, “Read in English ›” opens a machine translation · “Broker view” is a forecast, not reported results · checked 2026-11-06